irinotecan has been researched along with cardiovascular agents in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agu, RU; Feridooni, T; Mac Donald, C; Shao, D; Yeung, P | 1 |
1 other study(ies) available for irinotecan and cardiovascular agents
| Article | Year |
|---|---|
Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cardiovascular Agents; Cell Death; Cell Line; Cell Survival; Dexrazoxane; Diltiazem; Doxorubicin; Humans; Inhibitory Concentration 50; Irinotecan; Losartan; Myoblasts; Rats | 2013 |